中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

111 records (took 0.025 seconds)

    DYNAMIC ADJUSTMENT OF A CORRECTION FACTOR OF A USER BASED ON GLUCOSE VALUES
    1.
    发明申请
    DYNAMIC ADJUSTMENT OF A CORRECTION FACTOR OF A USER BASED ON GLUCOSE VALUES 有权

    公开(公告)号：US20250058042A1

    公开(公告)日：2025-02-20

    申请号：US18800698

    申请日：2024-08-12

    Applicant: INSULET CORPORATION

    Inventor： Joon Bok LEE ,  Yibin ZHENG ,  William WHITELEY ,  Jason O’CONNOR

    IPC: A61M5/142

    Abstract: The exemplary embodiments may provide a correction factor (CF) for a user that is dynamically adjustable based on current glucose level. In some exemplary embodiments, the CF of the user is adjusted based on the current glucose level of the user. As the current glucose level of the user increases to be above a threshold, the CF may be adjusted to reflect a decrease in the insulin sensitivity of the user. This adjustment may cause the control system to increase the amount of insulin delivered to the user as the glucose level of the user exceeds the threshold. Similarly, the CF of the user may be adjusted based on the current target glucose level of the user or based on a combination of the current glucose level of the user and the current target glucose level of the user.

    THRESHOLD BASED AUTOMATIC GLUCOSE CONTROL RESPONSE
    9.
    发明申请
    THRESHOLD BASED AUTOMATIC GLUCOSE CONTROL RESPONSE 有权

    公开(公告)号：US20220379029A1

    公开(公告)日：2022-12-01

    申请号：US17824494

    申请日：2022-05-25

    Applicant: Insulet Corporation

    Inventor： Ashutosh ZADE ,  Joon Bok LEE ,  Yibin ZHENG

    IPC: A61M5/172 ,  G16H20/17 ,  A61B5/145 ,  A61B5/00 ,  G16H40/63 ,  A61M5/142

    Abstract: Provided is a wearable medical device that includes a processor or logic circuitry. The wearable medical device may include a memory storing instructions that, when executed by the processor or logic circuitry, configure the wearable medical device to determine, by the processor or the logic circuitry, that an event affecting a blood glucose measurement value trend of a user has occurred. Based on the occurrence of the event, the processor or the logic circuitry may select a mode of operation of the analyte sensor, and generate a signal indicating the selected mode of operation. The mode of operation may correspond to a sampling frequency of a physical attribute or physiological condition of a user of the wearable medical device.

    DEVICES AND METHODS FOR INITIALIZATION OF DRUG DELIVERY DEVICES USING MEASURED ANALYTE SENSOR INFORMATION
    10.
    发明申请
    DEVICES AND METHODS FOR INITIALIZATION OF DRUG DELIVERY DEVICES USING MEASURED ANALYTE SENSOR INFORMATION 有权

    公开(公告)号：US20220347386A1

    公开(公告)日：2022-11-03

    申请号：US17730839

    申请日：2022-04-27

    Applicant: Insulet Corporation

    Inventor： Ashutosh ZADE ,  Joon Bok LEE ,  Yibin ZHENG

    IPC: A61M5/172 ,  G16H20/13 ,  G16H20/17 ,  G16H40/67

    Abstract: Disclosed are processes and techniques implementable by a drug delivery system to maintain optimal drug delivery for a patient according to a treatment plan. The disclosed techniques enable a new drug delivery device that is exchanged for a previous drug delivery device to operate using analyte-based drug delivery control immediately during initialization instead of having to wait for a warm-up period. For example, a drug delivery device may include a processor and a memory storing instructions that, when executed by the processor, operate the drug delivery device to receive a present analyte measurement value from an analyte sensor during an initialization of the drug delivery device, receive backfill values measured by the analyte sensor prior to the initialization, calculate a dosage of a drug using the present analyte measurement value and the backfill values, and deliver the dosage of the drug. Other embodiments are described.

Patent Agency Ranking